台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    123.0
  • 漲跌
    ▼2.0
  • 漲幅
    -1.60%
  • 成交量
    32
  • 產業
    上櫃 生技醫療類股
  • 66人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-國票 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

國票 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.000.1125.00123.00-0.112-0.67%
2025/01/080.1130.0000.00131.500.1130.63%
2024/11/2000.000130.00130.00021-0.18%
2024/11/190129.5000.00131.000220.18%
2024/11/1500.000134.50130.00023-0.03%
2024/11/1300.000134.50133.000230.00%
2024/11/120133.5000.00131.500240.03%
2024/11/1100.000133.00135.50025-0.05%
2024/11/0700.000.2138.35136.00-0.224-0.70%
2024/11/040.1135.000136.02136.000240.08%
2024/11/010.2135.1400.00137.000.2230.68%
2024/10/1500.000134.00132.00024-0.03%
2024/10/110133.0000.00133.000230.03%
2024/09/2400.000.3132.00132.00-0.321-1.38%
2024/09/230.3133.0000.00133.500.3191.48%
2024/09/1900.000139.50137.50016-0.07%
2024/09/1800.000.3139.62138.00-0.315-2.25%
2024/09/160138.0000.00139.500150.10%
2024/09/130.3138.0000.00138.500.3152.24%
2024/09/0600.000136.00134.50014-0.08%
2024/09/020136.0000.00136.000130.08%
2024/08/0500.000.2145.01137.50-0.212-1.34%
2024/08/0200.000.1153.02152.00-0.111-0.86%
2024/07/3000.000160.00160.00011-0.09%
2024/07/290.3157.370165.45160.500.3112.25%
2024/07/2200.000161.00161.00011-0.09%
2024/07/190161.5000.00162.000110.26%
2024/07/1800.000162.50162.00011-0.41%
2024/07/160160.000160.00161.000100.16%
2024/07/150159.0000.00160.000100.27%
2024/06/2400.000162.00160.0009-0.10%
2024/06/2100.000.1160.88162.50-0.110-1.07%
2024/06/1900.000.1157.50157.00-0.110-0.85%
2024/06/1100.000.1154.50156.50-0.111-0.76%
2024/06/070.1156.5000.00158.000.1110.57%
2024/06/0600.000.1158.00158.00-0.111-0.53%
2024/06/0500.000159.53160.00011-0.14%
2024/06/040.1156.0900.00157.000.1100.79%
2024/05/300.2150.5100.00152.000.2102.01%
2024/05/240152.0000.00150.000110.01%
2024/05/2100.000.2150.35153.00-0.210-1.58%
2024/05/200.2156.3800.00150.000.2101.65%
2024/04/3000.000.1154.00150.00-0.110-0.49%
2024/04/290.1154.0000.00154.000.1100.50%
2024/04/090157.5000.00160.000100.02%
2024/04/0200.000.2162.50158.00-0.210-1.65%
2024/04/010.2157.5000.00158.000.2101.63%
2024/03/2900.000159.00157.50011-0.11%
2024/03/280156.5000.00158.500110.12%
2024/03/1300.000.1155.10156.00-0.110-1.41%
2024/03/120.1156.9200.00157.500.1101.42%
2024/02/2700.000.1153.10152.00-0.19-0.81%
2024/02/230.1151.0000.00151.500.190.82%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章